Craig Pierson, a founder alongside Dr. Vnook, has been appointed Director at Kaida BioPharma. Mr. Pierson is a life sciences investor and company builder with more than 25 years of experience in ...

Cancer is never an easy foe, but some types are more stubborn than others. Ovarian cancer is one of the hardest to treat. But there are signs of progress. Several recent studies have used new ...

Scientists from University of California, Los Angeles, Harvard University, and elsewhere have developed what they claim is the first comprehensive road map of how the ovarian reserve forms in primates ...

Preclinical evidence supports azenosertib ADC combinations as potential promising therapeutic strategies for Triple-Negative Breast Cancer ...

Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University, Harvard Medical School (HMS), and Duke University, in collaboration with Gameto, report that they have ...

Scientists find finerenone may stimulate ovarian follicles and help restore fertility in women with POI, offering a potential ...

In A Nutshell A natural compound in grapes, resveratrol, can bind to key ovarian cancer proteins in computer models. Lab studies suggest it may slow tumor growth, reduce inflammation, and boost ...

Women with obesity, even those with regular menstrual cycles, have suppressed ovarian follicle development and reduced production of reproductive hormones, which may underlie reduced fertility, ...

Researchers identified finerenone as a potential treatment for POI. Preclinical findings show the drug stimulates follicle ...

AMSTERDAM, November 29th 2007 – With the genomic revolution radical improvement has been made in methods of detection of ovarian cancer. This is of the utmost importance, since the chances of ...